-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Tectonic Therapeutic, Raises Price Target to $85

Benzinga·05/15/2025 14:59:50
Listen to the news
Mizuho analyst Uy Ear maintains Tectonic Therapeutic (NASDAQ:TECX) with a Outperform and raises the price target from $51 to $85.